MEI/Kyowa Kirin Show More Data Supporting Zandelisib’s Safety Profile

MEI and Kyowa Kirin presented data at EHA for the PI3K-delta inhibitor zandelisib • Source: Shutterstock

More from Clinical Trials

More from R&D